Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

Jay Epstein, Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf

OnderzoeksoutputAcademicpeer review

3 Citaten (Scopus)
17 Downloads (Pure)


Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in
low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized
quality standards should collect CCP.
Originele taal-2English
Aantal pagina's2
Tijdschriftnpj Vaccines
Nummer van het tijdschrift1
StatusPublished - 1-dec.-2020
Extern gepubliceerdJa

Citeer dit